FOXO1 and rhabdomyosarcoma: Dagher et al. performed a pilot trial of vaccination with EWS-FLI-1 and PAX3-FKHR fusion peptides loaded on monocytes/immature dendritic cell populations in ESFT and alveolar rhabdomyosarcoma, respectively.